Radiolabeled glutaminylcyclase (QC) inhibitors as imaging agents, in particular, but not exclusively, as medical imaging agents for the detection of neurological disorders and pharmaceutical compositions, methods and kits for detecting neurological disorders, using the radiolabeled inhibitors.